IDC-G103

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameIDC-G103
Drug Alias Nameherpes simplex 2 virus vaccine (Immune Design)SP-0148G-103IDC-G103
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionToll like receptor 4 agonists
TargetsToll like receptor 4
Therapy Area/IndicationsHerpes Simplex Virus Type 2 Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesImmune Design Corp
China Registration ClassN/A

Develop Information

Active CompaniesSanofi Pasteur SaImmune Design Corp
Inactive CompaniesN/A
Active IndicationsHerpes Simplex Virus Type 2 Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A